145 related articles for article (PubMed ID: 3116713)
1. Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
Sakuragawa N; Kondo S; Katoh M; Takahashi K; Koide T
Thromb Res; 1987 Jul; 47(2):147-53. PubMed ID: 3116713
[TBL] [Abstract][Full Text] [Related]
2. Detection of antithrombin III microheterogeneity.
Milner AE; Burnett D; Rutter J; Bradwell AR
Thromb Res; 1985 Jan; 37(1):127-34. PubMed ID: 3983894
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and genetic aspects of antithrombin III deficiency and abnormal antithrombin III].
Tsuji H
Rinsho Ketsueki; 1991 May; 32(5):481-6. PubMed ID: 1870264
[TBL] [Abstract][Full Text] [Related]
4. [The diagnosis of congenital antithrombin III deficiency and abnormality].
Takahashi K; Yamagishi R; Sakuragawa N
Rinsho Byori; 1987 May; 35(5):505-10. PubMed ID: 3302410
[No Abstract] [Full Text] [Related]
5. Congenital antithrombin III deficiency (AT-III Kyoto): identification of a point mutation altering arginine-406 to methionine behind the reactive site.
Nakagawa M; Tanaka S; Tsuji H; Takada O; Uno M; Hashimoto-Gotoh T; Wagatsuma M
Thromb Res; 1991 Oct; 64(1):101-8. PubMed ID: 1776135
[TBL] [Abstract][Full Text] [Related]
6. Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.
De Stefano V; Leone G; Mastrangelo S; Lane DA; Girolami A; de Moerloose P; Sas G; Abildgaard U; Blajchman M; Rodeghiero F
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):7-15. PubMed ID: 8180341
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antithrombin III microheterogeneity by isoelectric focusing in polyacrylamide gels and immunoblotting.
Daly M; Hallinan F
Thromb Res; 1985 Oct; 40(2):207-14. PubMed ID: 4071470
[TBL] [Abstract][Full Text] [Related]
8. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
Sakuragawa N; Takahashi K; Kondo S; Koide T
Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity of inherited antithrombin III deficiency.
Leone G; Valori VM; Cotumaccio R
N Engl J Med; 1983 Oct; 309(17):1063-5. PubMed ID: 6621648
[No Abstract] [Full Text] [Related]
11. Heterogeneity of the "classical" antithrombin III deficiency.
Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
[TBL] [Abstract][Full Text] [Related]
13. [Restriction fragment length polymorphisms of the antithrombin III gene--examination of the normal Japanese, abnormal AT III (Toyama) and AT III deficient families].
Oguma Y; Sakuragawa N; Hiraga K
Rinsho Byori; 1989 Apr; Spec No 81():64-74. PubMed ID: 2569046
[No Abstract] [Full Text] [Related]
14. Human antithrombin III heterogeneity: a study by isoelectrofocusing and crossed immunoelectrofocusing.
Leone G; Valori VM; Cotumaccio R; Massi G
Haemostasis; 1983; 13(6):369-73. PubMed ID: 6667904
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic use of antithrombin III concentrate following surgery in congenital antithrombin III deficiency.
Hambley H; Davidson JF; Walker ID; Menzies T
Clin Lab Haematol; 1987; 9(1):27-31. PubMed ID: 3581714
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
[TBL] [Abstract][Full Text] [Related]
18. The antithrombin III gene polymorphism in Japan: examination for haplotypes relevant to disordered antithrombin III biosynthesis.
Oguma Y; Sakuragawa N; Hiraga K
Thromb Res; 1992 Mar; 65(4-5):519-31. PubMed ID: 1352068
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin III Toyama: a congenital antithrombin III abnormality with recurrent thrombophlebitis.
Takahashi K; Kondo S; Sakuragawa N
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1895-905. PubMed ID: 3836552
[No Abstract] [Full Text] [Related]
20. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
